- Home
- GTLS vs HALO Comparison
GTLS vs HALO Comparison
Compare GTLS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTLS
- HALO
- Stock Information
- Founded
- GTLS 1859
- HALO 1998
- Country
- GTLS United States
- HALO United States
- Employees
- GTLS N/A
- HALO N/A
- Industry
- GTLS Metal Fabrications
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GTLS Industrials
- HALO Health Care
- Exchange
- GTLS Nasdaq
- HALO Nasdaq
- Market Cap
- GTLS 9.2B
- HALO 7.4B
- IPO Year
- GTLS 1992
- HALO N/A
- Fundamental
- Price
- GTLS $159.32
- HALO $67.73
- Analyst Decision
- GTLS Strong Buy
- HALO Buy
- Analyst Count
- GTLS 12
- HALO 9
- Target Price
- GTLS $203.17
- HALO $63.78
- AVG Volume (30 Days)
- GTLS 693.2K
- HALO 1.9M
- Earning Date
- GTLS 05-01-2025
- HALO 05-06-2025
- Dividend Yield
- GTLS N/A
- HALO N/A
- EPS Growth
- GTLS 416.59
- HALO 55.40
- EPS
- GTLS 4.96
- HALO 3.76
- Revenue
- GTLS $4,211,100,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- GTLS $14.10
- HALO $20.06
- Revenue Next Year
- GTLS $9.71
- HALO $24.20
- P/E Ratio
- GTLS $32.10
- HALO $18.02
- Revenue Growth
- GTLS 11.65
- HALO 25.64
- 52 Week Low
- GTLS $101.60
- HALO $41.28
- 52 Week High
- GTLS $220.03
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- GTLS 59.78
- HALO 63.83
- Support Level
- GTLS $148.50
- HALO $58.38
- Resistance Level
- GTLS $158.82
- HALO $70.51
- Average True Range (ATR)
- GTLS 6.80
- HALO 2.38
- MACD
- GTLS 3.68
- HALO 0.92
- Stochastic Oscillator
- GTLS 86.93
- HALO 80.20
About GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.